INFORMATION BY CANCER TYPE

Lung

Opdivo Exceeds Expectations for Lung Cancer Survival
BY Lauren M. Green
Opdivo (nivolumab) showed better long-term survival rates than expected for patients with metastatic non-small cell lung cancer (NSCLC).
Big Change May Be Coming for Frontline NSCLC
BY Gina Columbus
The results of phase 3 FLAURA trial could potentially change the treatment paradigm for some patients with lung cancer.
Living with Lung Cancer
Edward S. Kim, MD, provides suggestions to patients given a new diagnosis of lung cancer on where, and how, to seek support for questions regarding the cancer journey.
Immunotherapy May Be a Treatment Option for Mesothelioma
BY Allie Casey
Patients with mesothelioma may be getting a new second-line treatment, thanks to results from a recent immunotherapy trial.
Young Woman's Fertility Preservation Procedure Leads to Stage 4 Lung Cancer Diagnosis
BY Katie Kosko
After a diagnosis of triple-negative breast cancer, Bekah Cunningham went to have a fertility preservation procedure, which ended up discovering another cancer in her lungs.
Tagrisso Gets Full Approval in Lung Cancer
BY Silas Inman
Tagrisso (osimertinib) was granted a regular Food and Drug Administration (FDA) approval to treat some patients with lung cancer.
What to Expect in the Lung Cancer Clinic
To help patients understand the protocol for being treated with chemotherapy, Edward S. Kim, MD, and Mark A. Socinski, MD, provide an overview of the treatment process and highlight the team of healthcare professionals that play a role in managing a patient through therapy.
Considerations When Deciding on a Lung Cancer Treatment
With various options available for the management of lung cancer, Edward S. Kim, MD, and Mark A. Socinski, MD, reveal how oncologists make treatment recommendations for appropriate patients and monitor for adverse events.
Drugs That Target Tumor Blood Vessels in Lung Cancer
Edward S. Kim, MD, and Mark A. Socinski, MD, explain how targeted therapies work in lung cancer and remark on the potential benefits of adding certain targeted drugs to chemotherapy.
Chemotherapy in Lung Cancer
Mark A. Socinski, MD, provides an overview of advances in chemotherapy treatment for nonsquamous, non–small cell lung cancer and highlights the side effects that are most commonly associated with certain regimens.
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Lung CURE discussion group.
Search Cancer Drugs & Terms
Treatment
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Non-Small Cell Lung Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of non-small cell lung cancer.
Small Cell Lung Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of small cell lung cancer.
Prevention, Genetics, Causes
Information related to prevention, genetics, risk factors
Lung Cancer Prevention (PDQ®)
Expert-reviewed information summary about factors that may influence the risk of developing lung cancer and about research aimed at the prevention of this disease.
Screening and Testing
Information about methods of cancer detection including new imaging technologies, tumor markers, and biopsy procedures
Lung Cancer Screening (PDQ®)
Expert-reviewed information summary about tests used to detect or screen for lung cancer.
x